Medical Tests (30)
Diagnostic Testing (11)

Note:

Some component of this panel might be part of the comprehensive metabolic panel.


Note:

Rule out cancer of islet cells.


Note:

EGFR is expressed 30-50% in Pancreatic ductal adenocarcinoma (PDAC). http://www.ncbi.nlm.nih.gov/pubmed/26361407


Note:

Not specific for pancreas cancer, but helpful in therapy treatment.

Other Supportive/Alternative Tests (9)

Note:

Determine therapeutic strategy for cancer therapeutics such as Tegafur.


Note:

Alternative to specif gene markers. Good for therapy selection and monitoring.


Note:

Individual cancer test tissue specific is recommended.